Blood Ammonia Reduction by Potassium Exchange Resin
- 1 August 1963
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 87 (2), 296-300
- https://doi.org/10.1001/archsurg.1963.01310140104018
Abstract
Introduction Hepatic coma, a consequence of severe liver disease, is usually associated with elevated levels of blood ammonia and derangements of serum electrolytes and pH. Treatment of hepatic coma may be directed toward lowering of the blood ammonia level once this elevation has occurred or preventing the absorption of the products of protein digestion within the gastrointestinal tract. Several methods have been employed to control blood ammonia. Neomycin is useful in removing urea-splitting organisms from the intestine, thereby limiting the amount of ammonia absorbed into the portal circulation.1The side effects of neomycin treatment, however, impair its usefulness. Hypothermia lowers blood ammonia, probably by limiting bacterial action.2,3Arginine and glutamic acid4-6enjoyed brief popularity because of the belief that they aided the metabolism of ammonia and its elimination via the Krebs urea cycle. Hemodialysis7is effective in clearing the blood of ammonia, but the technique isThis publication has 6 references indexed in Scilit:
- Management of Hyperkalemia with a Cation-Exchange ResinNew England Journal of Medicine, 1961
- Treatment of the Oliguric Patient with a New Sodium-Exchange Resin and SorbitolNew England Journal of Medicine, 1961
- The ammonia content of blood and plasmaAnalytical Biochemistry, 1960
- NEUROPSYCHIATRIC COMPLICATIONS FOLLOWING CHLORO-THIAZIDE THERAPY IN PATIENTS WITH HEPATIC CIRRHOSIS - POSSIBLE RELATION TO HYPOKALAEMIA1959
- CHLOROTHIAZIDE IN LIVER DISEASEAnnals of the New York Academy of Sciences, 1958
- Treatment of Hepatic Coma with L-Glutamic AcidNew England Journal of Medicine, 1955